Neoadjuvant In Situ Immunomodulation Enhances Systemic Antitumor Immunity against Highly Metastatic Tumors. Oba T, Kajihara R, Yokoi T, Repasky EA, et al. Cancer Res 2021;81:6183-6195.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Oba T, Kajihara R, Yokoi T, Repasky EA, et al. Neoadjuvant In Situ Immunomodulation Enhances Systemic Antitumor Immunity against Highly Metastatic Tumors. Cancer Res 2021;81:6183-6195.
PMID: 34666993